About the journal
Translational Lung Cancer Research is an open-access journal published by AME Publishing Company in Hong Kong SAR China. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- AME Publishing Company
- ISSN
- 2218-6751 · 2226-4477
- Country
- Hong Kong SAR China
- Access
- Open access
- Official website
- http://tlcr.thepbpc.org
Index listings
- PUBMED · 2023-01-31
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2719
Last recorded publication year
2026
h-index
78
i10-index
997
From OpenAlex open data (CC0).
Editorial & policy4
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
Identity & continuity3
- Alternate titles
- TLCR
- Source type
- journal
- NLM unique ID (PubMed)
- 101646875
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
Show all subjects (50)
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Pleural and Pulmonary Diseases
- Pleural and Pulmonary Diseases
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Occupational and environmental lung diseases
- Occupational and environmental lung diseases
- Inflammatory Biomarkers in Disease Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Advanced Radiotherapy Techniques
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Immunotherapy and Immune Responses
- Advanced Radiotherapy Techniques
- Immunotherapy and Immune Responses
- Brain Metastases and Treatment
- Tracheal and airway disorders
- Tracheal and airway disorders
- Brain Metastases and Treatment
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- RNA modifications and cancer
- RNA modifications and cancer
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Medical Imaging and Pathology Studies
- Medical Imaging and Pathology Studies
- Immune cells in cancer
- Immune cells in cancer
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ